Success Metrics

Clinical Success Rate
76.7%

Based on 56 completed trials

Completion Rate
77%(56/73)
Active Trials
0(0%)
Results Posted
50%(28 trials)
Terminated
17(19%)

Phase Distribution

Ph not_applicable
16
18%
Ph early_phase_1
3
3%
Ph phase_2
27
30%
Ph phase_3
8
9%
Ph phase_4
20
22%
Ph phase_1
16
18%

Phase Distribution

19

Early Stage

27

Mid Stage

28

Late Stage

Phase Distribution90 total trials
Early Phase 1First-in-human
3(3.3%)
Phase 1Safety & dosage
16(17.8%)
Phase 2Efficacy & side effects
27(30.0%)
Phase 3Large-scale testing
8(8.9%)
Phase 4Post-market surveillance
20(22.2%)
N/ANon-phased studies
16(17.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.7%

56 of 77 finished

Non-Completion Rate

27.3%

21 ended early

Currently Active

0

trials recruiting

Total Trials

91

all time

Status Distribution
Completed(56)
Terminated(21)
Other(14)

Detailed Status

Completed56
Terminated17
unknown14
Withdrawn4

Development Timeline

Analytics

Development Status

Total Trials
91
Active
0
Success Rate
76.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (3.3%)
Phase 116 (17.8%)
Phase 227 (30.0%)
Phase 38 (8.9%)
Phase 420 (22.2%)
N/A16 (17.8%)

Trials by Status

terminated1719%
unknown1415%
completed5662%
withdrawn44%

Recent Activity

Clinical Trials (91)

Showing 20 of 91 trialsScroll for more
NCT03748966Early Phase 1

Calcitriol Monotherapy for X-Linked Hypophosphatemia

Completed
NCT06261905Phase 1

Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System

Completed
NCT02962102Phase 2

Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury

Completed
NCT02859896Phase 3

Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis

Terminated
NCT02224144Phase 2

Bone Mass and Strength After Kidney Transplantation

Completed
NCT01350934Phase 4

A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)

Completed
NCT03103750Phase 1

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD

Completed
NCT04386811Phase 1

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning.

Terminated
NCT04967469Not Applicable

Comparison of Serum Calcium Level Between Preoperative Vitamin D and Non-vitamin D Regimen of Total Parathyroidectomy in End-stage Renal Failure Patients in Rajavithi Hospital

Completed
NCT01725113Phase 4

Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol

Terminated
NCT04801303Phase 4

Evaluation of the Effects of Calcitriol's in the Neurological Symptoms of Friedreich's Ataxia Patients

Completed
NCT04826133Early Phase 1

Vitamin D and Cocaine Administration

Terminated
NCT05765617Phase 2

Effect Of Calcitriol On Neutrophil To Lymphocytes Ratio And High Sensitivity C-Reactive Protein Covid-19 Patients

Completed
NCT05415254Not Applicable

Calcitriol Supplementation in COVID-19 Patients

Unknown
NCT01293682Phase 2

Effects of High Dose Calcitriol in Breast Cancer Patients

Completed
NCT01868750Phase 2

Phase II Pre-operative Vitamin D Supplementation to Prevent Post-thyroidectomy Hypocalcemia

Completed
NCT02061384Phase 2

RA-2 13-cis Retinoic Acid (Isotretinoin)

Completed
NCT00925704Phase 1

The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers

Completed
NCT02125279Phase 4

Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

Completed
NCT04637360Not Applicable

Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

Completed

Drug Details

Intervention Type
DRUG
Total Trials
91